Townsend & Associates’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$19.7M Buy
67,012
+1,052
+2% +$277K 1.66% 24
2026
Q2
$16.2M Buy
65,960
+1,827
+3% +$505K 1.38% 31
2026
Q1
$18.3M Buy
64,133
+1,319
+2% +$392K 1.58% 23
2025
Q4
$17.1M Buy
62,814
+1,010
+2% +$274K 1.53% 26
2025
Q3
$16.6M Buy
61,804
+1,822
+3% +$496K 1.57% 24
2025
Q2
$16.8M Sell
59,982
-11,046
-16% -$3M 1.66% 21
2025
Q1
$18.5M Sell
71,028
-6,129
-8% -$1.51M 1.93% 16
2024
Q4
$17.9M Buy
77,157
+1,571
+2% +$361K 1.84% 23
2024
Q3
$17.2M Buy
75,586
+2,465
+3% +$510K 1.76% 23
2024
Q2
$14.7M Buy
73,121
+1,813
+3% +$375K 1.63% 28
2024
Q1
$15.5M Buy
71,308
+1,360
+2% +$286K 1.8% 23
2023
Q4
$14.3M Buy
69,948
+27,041
+63% +$5.77M 1.79% 19
2023
Q3
$8.97M Buy
42,907
+12,489
+41% +$2.48M 1.89% 16
2023
Q2
$5.82M Buy
30,418
+9,201
+43% +$1.7M 1.5% 21
2023
Q1
$3.94M Buy
21,217
+14,540
+218% +$2.63M 1.58% 21
2022
Q4
$1.24M Buy
+6,677
New +$1.16M 0.61% 56

Other funds holding CME

Townsend & Associates's CME Position: Q3 2026 in Review

Townsend & Associates increased its CME Group (CME) stake by 1.6% in Q3 2026, buying an estimated $277K and bringing the position to 67,012 shares worth $19.7M. The position accounts for 1.66% of the portfolio, ranked #24.

Townsend & Associates first reported a position in CME in Q4 2022 and has held it in 16 quarters since. 635 funds tracked by Wall St. Rank hold CME as of Q3 2026.

  • Townsend & Associates held 67,012 shares of CME Group worth $19.7M as of Q3 2026.
  • Townsend & Associates bought 1,052 CME Group shares in Q3 2026, an estimated $277K.
  • CME Group made up 1.66% of Townsend & Associates's portfolio in Q3 2026, its #24 holding.
  • Townsend & Associates first reported a position in CME Group in Q4 2022 and has held it in 16 quarters since.
  • 635 funds tracked by Wall St. Rank held CME Group as of Q3 2026.

Based on Townsend & Associates's 13F filing for Q3 2026, filed 23 Oct 2026.